Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07376603
What this trial is testing

IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Intensity-modulated RadiotherapyStage IB
Qiaojuan Guo 169
Testing effectiveness (Phase 2)Study completedNCT04350190
What this trial is testing

Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 25
Testing effectiveness (Phase 2)Looking for participantsNCT07392320
What this trial is testing

A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharangeal Cancer
Sun Yat-sen University 142
Not applicableLooking for participantsNCT05126160
What this trial is testing

Immune Score Based Radiomics in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 494
Large-scale testing (Phase 3)Looking for participantsNCT06095154
What this trial is testing

CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma by AJCC V8 Stage
Fujian Cancer Hospital 474
Early research (Phase 1)Active Not RecruitingNCT02065362
What this trial is testing

TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC

Who this might be right for
EBV-positive Nasopharyngeal Carcinoma
Baylor College of Medicine 14
Not applicableStudy completedNCT07139054
What this trial is testing

68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients

Who this might be right for
Nasopharyngeal Cancer
The First Affiliated Hospital of Xiamen University 31
Testing effectiveness (Phase 2)UnknownNCT05981157
What this trial is testing

Anrotinib and Tirelizumab in First-line Treatment of RM-NPC

Who this might be right for
Nasopharyngeal Carcinoma
Zhongshan People's Hospital, Guangdong, China 27
Not applicableUnknownNCT03048305
What this trial is testing

Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 200
Testing effectiveness (Phase 2)Study completedNCT00436800
What this trial is testing

Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sanofi 41
Large-scale testing (Phase 3)Study completedNCT00017511
What this trial is testing

Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral ComplicationsRadiation Toxicity
Daiichi Sankyo
Testing effectiveness (Phase 2)Looking for participantsNCT07528183
What this trial is testing

Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 62
Testing effectiveness (Phase 2)Ended earlyNCT05563272
What this trial is testing

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Who this might be right for
Cervical CancerColorectal CancerEsophageal Cancer+16 more
Telix Pharmaceuticals (Innovations) Pty Ltd 11
Not applicableLooking for participantsNCT06870435
What this trial is testing

Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas

Who this might be right for
Nasopharyngeal Carcinoma (NPC)ScreeningEpstein Barr Virus
Ming-Yuan Chen 68,649
Testing effectiveness (Phase 2)Study completedNCT00916097
What this trial is testing

NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)

Who this might be right for
Head and Neck Neoplasms
Sanofi 66
Early research (Phase 1)Study completedNCT01462474
What this trial is testing

Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 20
Testing effectiveness (Phase 2)UnknownNCT03778008
What this trial is testing

Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis

Who this might be right for
Stomatitis
Second Affiliated Hospital of Nanchang University 90
Not applicableLooking for participantsNCT06282497
What this trial is testing

Xerostomia-optimised IMRT Versus Standard IMRT in NPC

Who this might be right for
Nasopharyngeal Carcinoma ,Xerostomia,Radiotherapy
Zhongshan People's Hospital, Guangdong, China 524
Not applicableUnknownNCT02481089
What this trial is testing

Polymorphisms in Key Genes of Glycolytic Pathway: Influence on Radiosensitivity in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaSingle Nucleotide PolymorphismsRadiosensitivity
Hunan Province Tumor Hospital 600
Large-scale testing (Phase 3)UnknownNCT02944708
What this trial is testing

Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center 384
Next Page